QMedRx Considers the Benefits of Diversification
Recent studies provide further explanation of the current trends within the pharmaceutical markets of the USA, Egypt and Saudi Arabia. QMedRx, a specialty compounding pharmacy comments on these findings.
Online, July 24, 2012 (Newswire.com) - With several changes in health care occurring on an international level, many analysts within the pharmaceutical industry are observing market trends on a global scale. A new report from The Wall Street Journal highlights current trends within America, and assesses the state of pharmaceutical industries within Egypt and Saudi Arabia. In all three markets, each study holds a particular focus on the advent of generic medications, which are proving to be more popular in a recession-driven economy. Florida compounding pharmacy, QMedRx, notes that the diversification of major drug manufacturers into the generic field demonstrates a noteworthy shift in pharmaceutical trends.
The Wall Street Journal notes that first-world American pharmaceutical companies are already or on the brink of breaking into diversification. For many companies this decision is one that presents a high risk; some note that if a market for existing medications is already present, there is no need to research and launch new medications. However, some are finding that diversifying into low-risk consumer health-oriented markets or into production of generic medications could fill in current revenue gaps.
While QMedRx is a company that specializes in personalized medication-or compounded prescriptions that meet the individual needs of a patient-it still feels that evolution within western medicine is essential. The company notes that such safe strategies may present short-term benefits related to finances, but could thwart the development of necessary drugs to help advance medical care.
The article notes that generics within Saudi Arabia and Egypt are actually more prevalent and widely accepted in the market, and are already embraced by major manufacturers. While low-cost medications are available in Egypt, there are signs that leading companies are slow to produce new products due to market regulation issues. The industry in Saudi Arabia is reported to be much more stable, as the country provides citizens with free national healthcare services. The article explains how generic diversification is thriving in the country, "In addition to receiving pricing advantages, the local generics industry is supported by the government through incentives of free land, interest-free loans and a 10 percent subsidy to the production cost of medicines and pharmaceutical products."
Although the services of QMedRx are not as common as those in widespread American pharmacies, the company sees these studies as indication that the entire pharmaceutical industry is in transition. In a recent statement the company explains this importance, "As a specialty pharmacy working within an evolving health care system, diversification of service lines meets both the needs of physician preferences as well as future growth."
ABOUT:
QMedRx, Inc. is a specialty pharmacy and healthcare service company located in Florida. Since 1990, the company has provided top-notch in-home care to patients through Home Care Solutions, an ACHC-accredited pharmacy. Licensed in 44 states and approved by many major insurance providers, the company can provide convenient solutions to customer throughout the country. QMedRx is also known for its unique services that include nursing service care coordinators, customized compounded treatments and years of experience with evidence-based medicine.
To learn more about this specialty pharmacy and its services, visit www.qmedrx.com.